Last reviewed · How we verify
NCT06792188
Smartwatch-Based AI Model for OSA Prediction (SWOSA)
trial testing Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea in Obstructive Sleep Apnea of Adult in 147 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 147 |
| Start date | 3 February 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea
Conditions studied
- Obstructive Sleep Apnea of Adult — all drugs for Obstructive Sleep Apnea of Adult →
- Screening — all drugs for Screening →
- Smart Watch — all drugs for Smart Watch →
Sponsor
Seoul National University Hospital
Who can join
Adults 22 to 85, any sex, with Obstructive Sleep Apnea of Adult or Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop an artificial intelligence (AI) model for more accurately diagnosing obstructive sleep apnea (OSA) by collecting blood oxygen saturation and other health information during sleep using a smartwatch. OSA is common but often underdiagnosed, and the gold-standard diagnostic test, polysomnography, is costly and time-consuming. Smartwatches can provide a variety of health data, such as sleep patterns, blood oxygen saturation, and heart rate, which can help detect key symptoms and signs of OSA. By developing an AI model that uses smartwatch data to screen for OSA, this study seeks to offer a cost-effective and accessible diagnostic method, ultimately contributing to the early detection and improved treatment rates of OSA.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06792188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea of Adult
Currently open trials in the same condition.
- NCT06512779 — Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals · NA · recruiting
- NCT06117579 — Effect of Inspiratory Muscle Training in Obstructive Sleep Apnea Syndrome. · NA · recruiting
- NCT06447818 — Changes in Difficult Airway Markers After Surgery for Obstructive Sleep Apnoea Syndrome · recruiting
- NCT06103630 — Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device · NA · recruiting
- NCT06283095 — Management of Obstructive Sleep Apnea Syndrome by Expansion Palatoplasty · NA · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06792188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06792188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing